Cargando…

Allopurinol and the risk of stroke in older adults receiving medicare

BACKGROUND: Previous studies of allopurinol and stroke risk have provided contradictory findings, ranging from a protective effect to an increased risk. Our objective was to assess whether allopurinol use is associated with the risk of stroke in the elderly. METHODS: We used the 5 % random sample of...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jasvinder A., Yu, Shaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015204/
https://www.ncbi.nlm.nih.gov/pubmed/27604082
http://dx.doi.org/10.1186/s12883-016-0692-2
_version_ 1782452390811664384
author Singh, Jasvinder A.
Yu, Shaohua
author_facet Singh, Jasvinder A.
Yu, Shaohua
author_sort Singh, Jasvinder A.
collection PubMed
description BACKGROUND: Previous studies of allopurinol and stroke risk have provided contradictory findings, ranging from a protective effect to an increased risk. Our objective was to assess whether allopurinol use is associated with the risk of stroke in the elderly. METHODS: We used the 5 % random sample of Medicare beneficiaries from 2006–2012 to study the association of new allopurinol initiation and incident stroke. We used multivariable-adjusted Cox regression models adjusted for age, gender, race, Charlson index, and cardio-protective medications (beta-blockers, ACE inhibitors, diuretics, statins) to calculate hazards ratio (HR) with 95 % confidence intervals (CI). Sensitivity analyses adjusted for coronary artery disease (CAD) risk factors including hypertension, hyperlipidemia, diabetes, and smoking instead of Charlson index. RESULTS: Among 28,488 eligible episodes of incident allopurinol, 2,177 ended in incident stroke (7.6 % episodes). In multivariable-adjusted analyses, allopurinol use was associated with 9 % lower hazard ratio for stoke, 0.91 (95 % CI, 0.83 to 0.99). Compared to no allopurinol use, allopurinol use durations of 181 days to 2 years, 0.88 (95 % CI, 0.78 to 0.99) and >2 years, 0.79 (95 % CI, 0.65 to 0.96) were significantly associated with lower multivariable-adjusted hazard of stroke. Sensitivity analyses adjusted for CAD risk factors confirmed these findings. In subgroup analyses, significant associations were noted between allopurinol use and the risk of ischemic stroke, 0.89 (95 % CI, 0.81 to 0.98); associations were not significant for hemorrhagic stroke, 1.01 (95 % CI, 0.79 to 1.29). CONCLUSIONS: Allopurinol use is associated with lower risk of stroke overall, more specifically ischemic stroke. This association is evident after 6-months of allopurinol use, and the hazard reduction increases with longer duration of use. Future studies need to examine underlying mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-016-0692-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5015204
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50152042016-09-09 Allopurinol and the risk of stroke in older adults receiving medicare Singh, Jasvinder A. Yu, Shaohua BMC Neurol Research Article BACKGROUND: Previous studies of allopurinol and stroke risk have provided contradictory findings, ranging from a protective effect to an increased risk. Our objective was to assess whether allopurinol use is associated with the risk of stroke in the elderly. METHODS: We used the 5 % random sample of Medicare beneficiaries from 2006–2012 to study the association of new allopurinol initiation and incident stroke. We used multivariable-adjusted Cox regression models adjusted for age, gender, race, Charlson index, and cardio-protective medications (beta-blockers, ACE inhibitors, diuretics, statins) to calculate hazards ratio (HR) with 95 % confidence intervals (CI). Sensitivity analyses adjusted for coronary artery disease (CAD) risk factors including hypertension, hyperlipidemia, diabetes, and smoking instead of Charlson index. RESULTS: Among 28,488 eligible episodes of incident allopurinol, 2,177 ended in incident stroke (7.6 % episodes). In multivariable-adjusted analyses, allopurinol use was associated with 9 % lower hazard ratio for stoke, 0.91 (95 % CI, 0.83 to 0.99). Compared to no allopurinol use, allopurinol use durations of 181 days to 2 years, 0.88 (95 % CI, 0.78 to 0.99) and >2 years, 0.79 (95 % CI, 0.65 to 0.96) were significantly associated with lower multivariable-adjusted hazard of stroke. Sensitivity analyses adjusted for CAD risk factors confirmed these findings. In subgroup analyses, significant associations were noted between allopurinol use and the risk of ischemic stroke, 0.89 (95 % CI, 0.81 to 0.98); associations were not significant for hemorrhagic stroke, 1.01 (95 % CI, 0.79 to 1.29). CONCLUSIONS: Allopurinol use is associated with lower risk of stroke overall, more specifically ischemic stroke. This association is evident after 6-months of allopurinol use, and the hazard reduction increases with longer duration of use. Future studies need to examine underlying mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-016-0692-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-07 /pmc/articles/PMC5015204/ /pubmed/27604082 http://dx.doi.org/10.1186/s12883-016-0692-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Singh, Jasvinder A.
Yu, Shaohua
Allopurinol and the risk of stroke in older adults receiving medicare
title Allopurinol and the risk of stroke in older adults receiving medicare
title_full Allopurinol and the risk of stroke in older adults receiving medicare
title_fullStr Allopurinol and the risk of stroke in older adults receiving medicare
title_full_unstemmed Allopurinol and the risk of stroke in older adults receiving medicare
title_short Allopurinol and the risk of stroke in older adults receiving medicare
title_sort allopurinol and the risk of stroke in older adults receiving medicare
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015204/
https://www.ncbi.nlm.nih.gov/pubmed/27604082
http://dx.doi.org/10.1186/s12883-016-0692-2
work_keys_str_mv AT singhjasvindera allopurinolandtheriskofstrokeinolderadultsreceivingmedicare
AT yushaohua allopurinolandtheriskofstrokeinolderadultsreceivingmedicare